"UPMC Hillman Cancer Center - Natrona Heights (Medical Oncology) is a Cancer Treatment Center located in Natrona Heights.Visit our website to learn more about the conditions we treat and the services we offer. Schedule your appointment today. UPMC is committed to protecting our communities from the spread of COVID-19. We continue to require people who come to any UPMC facility to wear a facemask that covers their nose and mouth and to practice other preventative efforts like social distancing, even if fully vaccinated."

During the past decade, UPMC Cancer Center-Natrona Heights conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 9 clinical trials were completed, i.e. on average, 112.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UPMC Cancer Center-Natrona Heights" #1 sponsor was "National Cancer Institute (NCI)" with 9 trials, followed by "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "Radiation Therapy Oncology Group" with 4 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "SWOG Cancer Research Network" with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC Cancer Center-Natrona Heights" #1 collaborator was "National Cancer Institute (NCI)" with 11 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator and "Radiation Therapy Oncology Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "UPMC Cancer Center-Natrona Heights" are "Prostate Cancer" (3 trials), "Lung Cancer" (2 trials), "Metastatic Cancer" (2 trials), "Stage IIIA Lung Cancer AJCC v8" (2 trials) and "Stage IIIB Lung Cancer AJCC v8" (2 trials). Many other conditions were trialed in "UPMC Cancer Center-Natrona Heights" in a lesser frequency.

Most popular intervention types in "UPMC Cancer Center-Natrona Heights" are "Drug" (19 trials), "Radiation" (12 trials), "Biological" (10 trials), "Other" (10 trials) and "Procedure" (7 trials). Other intervention types were less common.

The name of intervention was led by "Cisplatin" (5 trials), "Laboratory Biomarker Analysis" (5 trials), "Paclitaxel" (5 trials), "Carboplatin" (4 trials) and "Computed Tomography" (4 trials). Other intervention names were less common.

The vast majority of trials in "UPMC Cancer Center-Natrona Heights" are 18 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "UPMC Cancer Center-Natrona Heights". undefined are not yet recruiting, 8 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in UPMC Cancer Center-Natrona Heights, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UPMC Cancer Center-Natrona Heights, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".